My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Archivos de la Sociedad Española de Oftalmología
Print version ISSN 0365-6691
Abstract
VLEMING, E.N.; PEREZ-RICO, C.; MONTES, M.A. and PAREJA, J.. Peristent corneal defects treated with botulinum toxin-induced ptosis. Arch Soc Esp Oftalmol [online]. 2007, vol.82, n.9, pp.547-550. ISSN 0365-6691.
Objectives: To evaluate the use of botulinum toxin (BTX) induced ptosis in the treatment of corneal pathology. Methods: We employed two BTX injections into the superior lid of 10 eyes (9 patients). We evaluated the degree of ptosis, its duration and the effect on the corneal lesion. Results: Complete ptosis resulted in seven eyes and the corneal pathology resolved in all of them. There were no relevant complications. Conclusions: BTX treatment is a simple and safe technique for treating refractory corneal pathology. It has significant advantages over surgical tarsorrhaphy and is especially useful where the pathology does not require surgery.
Keywords : Tarsorrhaphy; botulinum toxin; ptosis; persistent corneal defect; contact lens; autologous serum.